Optometry: Open Access
Open Access

Ocular surface disease; Eye infection; Dry eyes

Introduction

The most common form of OSD, dry eye syndrome occurs due to inadequate tear production or excessive tear evaporation, leading to dryness, irritation, and inflammation of the ocular surface. Dysfunction of the meibomian glands, which produce the lipid layer of tears, can result in poor tear film stability and increased evaporation, contributing to OSD symptoms. Allergic reactions affecting the eyes, such as allergic conjunctivitis, can cause inflammation and irritation of the ocular surface. Exposure to dry or windy conditions, air conditioning, smoke, and pollutants can exacerbate OSD symptoms by increasing tear evaporation or causing irritation. Conditions like autoimmune diseases (e.g., Sjögren's syndrome), diabetes, and rheumatoid arthritis can impact tear production and quality, contributing to OSD [1-4].

Methodology

Symptoms of ocular surface disease

Common symptoms of OSD include:

Dryness: Feeling of dryness or grittiness in the eyes.

Redness: Ocular surface inflammation leading to redness of the eyes.

Burning or stinging: Sensation of burning or stinging on the ocular surface.

Blurred vision: Vision may be intermittently blurred, especially after prolonged visual tasks.

Sensitivity to light: Increased sensitivity to light (photophobia).

Foreign body sensation: Feeling of something in the eye (like sand or grit).

Excessive tearing: Paradoxical response where the eyes produce excessive tears as a compensatory mechanism for dryness [5-8].

Diagnosis and evaluation

Diagnosis of OSD involves a comprehensive eye examination, which may include:

Symptom assessment: Detailed discussion of symptoms and their impact on daily activities.

Tear film evaluation: Assessment of tear quality, quantity, and stability through tests like tear breakup time (TBUT) and tear osmolarity measurement.

Ocular surface staining: Using dyes like fluorescein and lissamine green to visualize and assess damage to the cornea and conjunctiva.

Meibomian gland assessment: Evaluation of meibomian gland function and expression to detect MGD.

Management of ocular surface disease

Treatment and management of OSD depend on the underlying cause and severity of symptoms:

Artificial tears: Lubricating eye drops or gels to alleviate dryness and provide temporary relief.

Lid hygiene: Warm compresses and eyelid massages to improve meibomian gland function and reduce debris in eyelash follicles.

Anti-inflammatory medications: Prescription medications like cyclosporine (Restasis) or lifitegrast (Xiidra) to reduce ocular surface inflammation and improve tear production.

Punctal plugs: Small plugs inserted into the tear drainage ducts to conserve natural tears and increase eye moisture.

Nutritional supplements: Omega-3 fatty acids and other supplements that support healthy tear production and ocular surface integrity.

Environmental modifications: Avoiding dry or windy conditions, using humidifiers indoors, and protecting eyes from irritants.

Surgical interventions: In severe cases of MGD, procedures like meibomian gland probing or thermal pulsation therapy may be considered to improve gland function.

Prognosis and outlook

With appropriate management, many individuals with OSD can experience significant improvement in symptoms and preservation of ocular health. Early diagnosis and tailored treatment plans are essential for optimizing outcomes and preventing long-term complications such as corneal ulcers or scarring [9,10].

Conclusion

Ocular surface disease encompasses a range of conditions that affect the health and function of the eye's surface. From dry eye syndrome to meibomian gland dysfunction and allergic conjunctivitis, OSD can significantly impact quality of life if left untreated. Understanding the causes, recognizing symptoms early, and seeking prompt evaluation by an eye care professional are crucial steps in managing OSD effectively. Through a combination of lifestyle modifications, medications, and in some cases, surgical interventions, individuals can find relief from symptoms and maintain long-term ocular health.

As research continues to advance our understanding of OSD, ongoing developments in treatments offer hope for improved management and outcomes for patients worldwide.

1. Majowicz SE, Musto J, Scallan E, Angulo FJ, Kirk M, et al. (2010) Hoekstra RM, International Collaboration on Enteric Disease 'Burden of Illness S. The global burden of nontyphoidal Salmonella gastroenteritis. Clin Infect Dis 50: 882-889.

Indexed at, Google Scholar, Crossref

2. Hohmann EL (2001) Nontyphoidal salmonellosis.Clin Infect Dis 32: 263-269.

Indexed at, Google Scholar, Crossref

3. Relhan N, Pathengay A, Albini T, Priya K, Jalali S, et al. (2014) A case of vasculitis, retinitis and macular neurosensory detachment presenting post typhoid fever. J Ophthalmic Inflamm Infect 18: 4-23.

Indexed at, Google Scholar, Crossref

4. Sinha MK, Jalali S, Nalamada Semin S (2012) Review of endogenous endophthalmitis caused by Salmonella species including delayed onset Salmonella typhi endophthalmitis. Ophthalmol 27: 94-98.

Indexed at, Google Scholar, Crossref

5. Fusco R, Magli A, Guacci P (1986) stellate maculopathy due to Salmonella typhi. Ophthalmologica 192: 154-158.

Indexed at, Google Scholar, Crossref

6. Ellis MJ, Tsai CN, Johnson JW, French S, Elhenawy W, et al. (2019) A macrophage-based screen identifies antibacterial compounds selective for intracellular Salmonella Typhimurium. Nat Commun 10: 197

Indexed at, Google Scholar, Crossref

7. Stapels DAC, Hill PWS, Westermann AJ, Fisher RA, Thurston TL, et al. (2018) Salmonella persisters undermine host immune defenses during antibiotic treatment. Science 362: 1156-1160.

Indexed at, Google Scholar, Crossref

8. .Pirani V, Pelliccioni P, De Turris S, Rosati A, Franceschi A, et al. (2019) The Eye as a Window to Systemic Infectious Diseases: Old Enemies, New Imaging. J Clin Med 8: 1392.

Indexed at, Google Scholar, Crossref

9. .Fonollosa A, Giralt J, Pelegrin L (2009)Ocular syphilis–back again: understanding recent increases in the incidence of ocular syphilitic disease.Ocul Immunol Inflamm17: 207-212.

Indexed at, Google Scholar, Crossref

10. Albert DM, Raven ML (2016) Ocular Tuberculosis. Microbiol Spectr 0001-2016.

Indexed at, Google Scholar, Crossref